Searched for
THROMBOLYTIC
How to identify Gaboon Viper: Key physical features, range, habitat, and dietAfrica's Gaboon viper boasts the longest fangs of any venomous snake. This master of camouflage lives in forests and is a patient hunter. W...- Europe wakes up to critical medicine dependency on China, looks for ways to prevent possible crisis scenariosA coalition of health ministers in the EU is pushing for reduced dependency on Asia, primarily China, for essential medicines. They urge th...
- AI-powered device successfully treats blood clot in a 28-year-oldA 28-year-old man with acute pulmonary thromboembolism was successfully treated at Sir Gangaram Hospital using an AI-powered device designe...
- Sun Pharma scouting for innovative therapies to boost India businessApproved by the Indian drug regulator in May 2023, sovateltide can be administered within 24 hours for the treatment of ischemic stroke, al...
- What is the cost of diagnosis, treatment for strokesIn the fifth part of this series on major illnesses in India, we tell you the cost of diagnosis and treatment for strokes, so that you can ...
- Indian scientists develop clot-busting drug for heart patientsIndian scientists have developed a clot-busting cost-effective drug for heart patients which can also reduce the risk of internal bleeding.
- CSIR to focus on MSME sector; starts company to aid spinoffAfter developing a number of technologies for the societal & strategic areas, CSIR has now drawn up plans to focus on the micro, small and ...
- Now, we want to focus on small & medium enterprises: Samir K Brahmachari, CSIRThe country's largest laboratory cluster - the Council of Scientific & Industrial Research (CSIR), with 38 labs across the country under it...
- Cadila Q4 net dips 4.52% to Rs 171 croreThe company had posted a net profit of Rs 178.97 crore for in the same quarter last fiscal, Cadila Healthcare said in a filing to BSE.
- Hits and Misses: Everonn Education, Heidelberg Cement, HDIL & Cadila HealthcareShares of Everonn Education, India's largest technology-enabled education firm, were locked at the 20% upper circuit of 395.85 on Monday.
- Now, make way for the biotech copycatsIndian drug makers have already become a formidable force in bringing out generic forms of chemically-synthesised medicines, especially in ...
Load More
